Phase II Study of TAK228 in Relapsed Lymphoma
Clinical trial NCT02727777 · TERMINATED
Trial details
- NCT number
- NCT02727777
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2018-07-10
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.